AI-driven small molecule discovery, which underlies most drugs on the market, is a challenge being tackled through science and technology

AI-driven small molecule discovery, which underlies most drugs on the market, is a challenge being tackled through science and technology

Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery